ATLASense Biomed Ltd.
ATLASense Biomed is a healthcare technology company dedicated to developing advanced remote monitoring solutions. Their flagship system, REPHAEL, provides continuous, predictive, and ICU-grade remote patient monitoring, enabling early detection of health deterioration and supporting proactive care from hospital admission to home recovery. The company's mission is to transform patient care through innovative, scalable, and cost-effective medical monitoring technologies, with a focus on improving clinical decision-making and reducing healthcare costs worldwide.
Industries
Nr. of Employees
small (1-50)
ATLASense Biomed Ltd.
1 Ezer Weizman St., Hod Hasharon Israel, 4502552 P.O.B. 16187 Tel-Aviv Israel, 6116101
Patents
Products
ICU-grade wearable remote monitoring system (Basic and Premium tiers)
An end-to-end remote monitoring solution combining a chest-worn wearable device with cloud analytics and a clinician dashboard. Basic tier provides continuous telemetry (ECG, respiratory rate, cuffless BP, temperature, movement); Premium tier adds advanced analytics modules for continuous cardiac holter monitoring, heart-functionality metrics, respiratory-insufficiency index, early sepsis screening and fall-risk detection.
PolyMonitor wearable multi-sensor device
Chest-worn wearable module that houses multiple physiological and environmental sensors, transmits data to the cloud gateway and is designed for reuse with off-the-shelf electrodes.
ICU-grade wearable remote monitoring system (Basic and Premium tiers)
An end-to-end remote monitoring solution combining a chest-worn wearable device with cloud analytics and a clinician dashboard. Basic tier provides continuous telemetry (ECG, respiratory rate, cuffless BP, temperature, movement); Premium tier adds advanced analytics modules for continuous cardiac holter monitoring, heart-functionality metrics, respiratory-insufficiency index, early sepsis screening and fall-risk detection.
PolyMonitor wearable multi-sensor device
Chest-worn wearable module that houses multiple physiological and environmental sensors, transmits data to the cloud gateway and is designed for reuse with off-the-shelf electrodes.
Services
Provision of continuous, cloud-connected remote monitoring operations that deliver real-time vital-sign telemetry, clinician alerts, and prioritized notifications for hospital and home care.
Cloud-based analytics platform that applies machine-learning models to fused sensor data to generate early-warning scores and prioritized clinician decision support.
Support for pilot deployments, validation studies and hospital implementations to evaluate clinical performance and implement remote monitoring pathways.
Provision of continuous, cloud-connected remote monitoring operations that deliver real-time vital-sign telemetry, clinician alerts, and prioritized notifications for hospital and home care.
Cloud-based analytics platform that applies machine-learning models to fused sensor data to generate early-warning scores and prioritized clinician decision support.
Support for pilot deployments, validation studies and hospital implementations to evaluate clinical performance and implement remote monitoring pathways.
Expertise Areas
- Remote patient monitoring (RPM) systems
- AI-driven predictive analytics for acute deterioration
- Continuous cardiac telemetry and ECG interpretation
- Respiratory monitoring and early respiratory-deterioration prediction
Key Technologies
- Wearable multi-sensor platforms
- Cloud-based sensor-fusion algorithms
- AI / machine learning for physiological time-series
- Continuous multi-lead ECG telemetry (3-lead)
News & Updates
An Israeli-based start-up company wins Henry Ford Health System’s Global Health Tech Challenge for a predictive patient monitoring system.
An Israeli-based start-up company wins Henry Ford Health System’s Global Health Tech Challenge for a predictive monitoring system.
The company received a grant to develop predictive analytics for early sepsis detection, in collaboration with Prometheus.
ATLASense Biomed awarded a grant to develop breakthrough technology for respiratory deterioration prediction.
The system offers ICU-grade remote monitoring with predictive analytics, enabling proactive healthcare.
An Israeli-based start-up company wins Henry Ford Health System’s Global Health Tech Challenge for a predictive patient monitoring system.
An Israeli-based start-up company wins Henry Ford Health System’s Global Health Tech Challenge for a predictive patient monitoring system.
An Israeli-based start-up company wins Henry Ford Health System’s Global Health Tech Challenge for a predictive monitoring system.
The company received a grant to develop predictive analytics for early sepsis detection, in collaboration with Prometheus.
ATLASense Biomed awarded a grant to develop breakthrough technology for respiratory deterioration prediction.
The system offers ICU-grade remote monitoring with predictive analytics, enabling proactive healthcare.
An Israeli-based start-up company wins Henry Ford Health System’s Global Health Tech Challenge for a predictive patient monitoring system.